Companion Animal Ear Infection Treatment Market Report, 2032

Companion Animal Ear Infection Treatment Market – By Drug Type (Antibiotics, Antifungals, Corticosteroids), Animal Type (Dogs, Cats, Horses), Medication Type, Mode of Administration (Otic, Oral, Parenteral), Disease Type, Distribution Channel (Drug Store, Pet Store) – Global Forecast 2024 ­ 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing rate of pet ownership globally

3.2.1.2&nbsp;&nbsp;&nbsp; Growing advancements in veterinary medicine

3.2.1.3&nbsp;&nbsp;&nbsp; Rising prevalence of ear infections among pets

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Lack of compliance

3.2.2.2&nbsp;&nbsp;&nbsp; Side effects of medications

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Pipeline assessment

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6.1&nbsp;&nbsp;&nbsp; Supplier power

3.6.2&nbsp;&nbsp;&nbsp; Buyer power

3.6.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.6.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.6.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Drug Type, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Antibiotics

5.2.1&nbsp;&nbsp;&nbsp; Cephalosporins

5.2.2&nbsp;&nbsp;&nbsp; Penicillins

5.2.3&nbsp;&nbsp;&nbsp; Fluoroquinolones

5.2.4&nbsp;&nbsp;&nbsp; Imidazole

5.2.5&nbsp;&nbsp;&nbsp; Other antibiotics

5.3&nbsp;&nbsp;&nbsp; Antifungals

5.4&nbsp;&nbsp;&nbsp; Corticosteroids

5.5&nbsp;&nbsp;&nbsp; Cleaning agents

5.6&nbsp;&nbsp;&nbsp; Other drug types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Animal Type, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Dogs

6.3&nbsp;&nbsp;&nbsp; Cats

6.4&nbsp;&nbsp;&nbsp; Horses

6.5&nbsp;&nbsp;&nbsp; Other animal types

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Medication Type, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; OTC

7.3&nbsp;&nbsp;&nbsp; Prescription

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Mode of Administration, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Otic

8.3&nbsp;&nbsp;&nbsp; Oral

8.4&nbsp;&nbsp;&nbsp; Parenteral

8.5&nbsp;&nbsp;&nbsp; Topical

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Disease Type, 2018 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Otitis externa

9.3&nbsp;&nbsp;&nbsp; Otitis media

9.4&nbsp;&nbsp;&nbsp; Otitis interna

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2018 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; Veterinary hospital pharmacies

10.3&nbsp;&nbsp;&nbsp; Drug stores

10.4&nbsp;&nbsp;&nbsp; Pet specialty stores

10.5&nbsp;&nbsp;&nbsp; E-commerce

Chapter 11&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

11.1&nbsp;&nbsp;&nbsp; Key trends, by region

11.2&nbsp;&nbsp;&nbsp; North America

11.2.1&nbsp;&nbsp;&nbsp;U.S.

11.2.2&nbsp;&nbsp;&nbsp;Canada

11.3&nbsp;&nbsp;&nbsp; Europe

11.3.1&nbsp;&nbsp;&nbsp;Germany

11.3.2&nbsp;&nbsp;&nbsp;UK

11.3.3&nbsp;&nbsp;&nbsp;France

11.3.4&nbsp;&nbsp;&nbsp;Spain

11.3.5&nbsp;&nbsp;&nbsp;Italy

11.3.6&nbsp;&nbsp;&nbsp;Rest of Europe

11.4&nbsp;&nbsp;&nbsp; Asia Pacific

11.4.1&nbsp;&nbsp;&nbsp;Japan

11.4.2&nbsp;&nbsp;&nbsp;China

11.4.3&nbsp;&nbsp;&nbsp;India

11.4.4&nbsp;&nbsp;&nbsp;Australia

11.4.5&nbsp;&nbsp;&nbsp;Rest of Asia Pacific

11.5&nbsp;&nbsp;&nbsp; Latin America

11.5.1&nbsp;&nbsp;&nbsp;Brazil

11.5.2&nbsp;&nbsp;&nbsp;Mexico

11.5.3&nbsp;&nbsp;&nbsp;Rest of Latin America

11.6&nbsp;&nbsp;&nbsp; Middle East and Africa

11.6.1&nbsp;&nbsp;&nbsp;South Africa

11.6.2&nbsp;&nbsp;&nbsp;Saudi Arabia

11.6.3&nbsp;&nbsp;&nbsp;Rest of Middle East and Africa

Chapter 12&nbsp;&nbsp;&nbsp;Company Profiles

12.1&nbsp;&nbsp;&nbsp; Bayer AG

12.2&nbsp;&nbsp;&nbsp; Ceva Sante Animale

12.3&nbsp;&nbsp;&nbsp; Dechra Pharmaceuticals PLC

12.4&nbsp;&nbsp;&nbsp; Elanco Animal Health Incorporated

12.5&nbsp;&nbsp;&nbsp; Entod International

12.6&nbsp;&nbsp;&nbsp; Merck &amp; Co., Inc.

12.7&nbsp;&nbsp;&nbsp; Nextmune

12.8&nbsp;&nbsp;&nbsp; Penn Veterinary Supply, Inc.

12.9&nbsp;&nbsp;&nbsp; Piedmont Animal Health, Inc.

12.10&nbsp;&nbsp;&nbsp; Vedco, Inc.

12.11&nbsp;&nbsp;&nbsp; Vetnique Labs

12.12&nbsp;&nbsp;&nbsp; Vetoquinol S.A.

12.13&nbsp;&nbsp;&nbsp; Virbac S.A.

12.14&nbsp;&nbsp;&nbsp; Wedgewood Village Pharmacy, LLC

12.15&nbsp;&nbsp;&nbsp; Zoetis Inc. 
&nbsp;

Companion Animal Ear Infection Treatment Market

Get a free sample of this report